Riskpilot← Back to searchSign inGet full accessPhastar Denmark ApS
APSActiveCVR 30834909Blegdamsvej 124, 3.All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 200713 employees
Revenue 2024
DKK 24,3M
-16% vs 2023
EBITDA margin
6.8%
-66% vs 2023
Equity ratio
45.5%
Financial strength
Net profit 2024
DKK 729K
-79% vs 2023
| Revenue | DKK 24,3M | -16% |
| EBITDA | DKK 1,7M | -66% |
| Net profit | DKK 729K | -79% |
| Total assets | DKK 21,9M | +16% |
| Equity | DKK 10M | +8% |
| Employees | 13 | — |
Legal name
Phastar Denmark ApS
CVR number
30834909
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
12. september 2007
Share capital
DKK 125.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er konsulentvirksomhed indenfor pharma-industrien. The Company is a consulting business, specialised within the pharmaceutical industry.
Address
Blegdamsvej 124, 3.
Phone
+4531452916
Email
denmark@phastar.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.825 | 18.101 | 23.219 | 32.804 | 32.784 | 42.707 | 48.335 | 38.358 | 32.845 | 29.952 | 30.234 | 28.959 | 24.279 |
| Staff expenses | -5.935 | -8.528 | -11.459 | -13.789 | -18.662 | -26.362 | -31.683 | -31.839 | -31.647 | -28.472 | -24.929 | -24.112 | -22.617 |
| EBITDA | 2.528 | 4.320 | 3.148 | 5.202 | 4.599 | 1.352 | 4.130 | 6.519 | 1.197 | 1.481 | 5.305 | 4.847 | 1.662 |
| Depreciation & amort. | -48 | -61 | -79 | -81 | -78 | -290 | -81 | -64 | -205 | -147 | -121 | -306 | -655 |
| EBIT | 2.480 | 4.259 | 3.069 | 5.121 | 4.521 | 1.063 | 4.048 | 6.455 | 993 | 1.333 | 5.184 | 4.540 | 1.006 |
| Net financials | -61 | -59 | -34 | -47 | -27 | -43 | -105 | -284 | -96 | -819 | -139 | -100 | -71 |
| Profit before tax | 2.419 | 4.200 | 3.035 | 5.075 | 4.494 | 1.019 | 3.943 | 6.171 | 897 | 514 | 5.045 | 4.440 | 935 |
| Tax | 618 | 1.073 | 756 | 1.214 | 994 | 243 | 875 | 1.317 | 304 | 113 | 1.111 | 1.011 | 205 |
| Net profit | 1.801 | 3.126 | 2.279 | 3.861 | 3.500 | 777 | 3.068 | 4.854 | 592 | 401 | 3.934 | 3.429 | 729 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.373 | 7.608 | 6.653 | 7.194 | 10.802 | 11.059 | 20.588 | 19.546 | 19.355 | 13.479 | 17.664 | 18.907 | 21.945 |
| Equity | 1.414 | 3.794 | 995 | 1.951 | 3.709 | 1.581 | 4.649 | 10.463 | 5.845 | 3.887 | 5.821 | 9.250 | 9.979 |
| Long-term debt | 447 | 74 | 74 | 82 | 75 | 570 | 0 | 0 | 2.210 | 1.903 | 1.943 | 2.011 | 2.111 |
| Short-term debt | 3.957 | 3.809 | 5.653 | 5.242 | 7.060 | 9.449 | 15.909 | 9.059 | 11.292 | 7.670 | 9.895 | 7.413 | 9.416 |
| Total debt | 3.957 | 3.809 | 5.653 | 5.242 | 7.060 | 9.449 | 15.909 | 9.059 | 13.502 | 9.573 | 11.839 | 9.424 | 11.527 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20122024
Equity ratio
45.5%
This company
38.2%
Market median
+19% vs market
20122024
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20122024
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20122024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20122024
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NB Management | Management | 2019 | — | — |
SM Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
AJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
JG Management | Management | 2019 | — | — |
MP Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 | |
NIELS BOTH HOLDING ApS | Company | 20.0% | 20.0% | 2010 |
JJ PHARMA CONSULT ApS | Company | 20.0% | 20.0% | 2014 |
| Individual | 10.0% | 10.0% | 2019 | |
DENEERGAARD ApS | Company | 10.0% | 10.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Phastar Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Blondie Both | Management | 0 companies |
| Scott McGregor | Chief Executive Officer | 0 companies |
| Andrew James MacGarvey | Chief Executive Officer | 0 companies |
| Jack Groth Jacobsen | Management | 0 companies |
| Meirion Puw Rees | Management | 0 companies |
| David Peter Iberson-Hurst | Board of Directors | 0 companies |
| Martin Horst Sørensen | Board of Directors | 0 companies |
| Adam de Neergaard | Board of Directors | 0 companies |